Structuring a life sciences website for scientific and commercial audiences

The hardest structural problem in a life sciences website redesign is that two very different readers share the same front door. A scientist arrives to judge the evidence. A commercial buyer arrives to judge the fit. Build the site around either one alone and the other feels lost. We structure these sites so each audience follows its own path without being forced through the other's journey, and so the homepage does its job for both.

Design for two readers with different questions

The scientific reader and the commercial reader are not simply at different stages of the same funnel. They ask different questions and trust different signals. Understanding that difference is the whole of the structural work.

• The scientific reader wants methods, data, primary sources, and the people behind the work. Credibility is earned through depth and precision, and a vague claim loses them.
• The commercial reader wants capabilities, applications, proof of delivery, and a clear route to a conversation. They value depth too, but they need the path to a decision to be obvious.

A life sciences site that treats these as one audience ends up serving a muddled middle that satisfies neither. The structure has to let each reader self-select early and then stay on a track built for them.

Let the homepage route, not resolve

The homepage of a life science website does not need to answer every question. Its job is to route. Within the first screen, both readers should recognize that the site is for them and see the path that leads to what they came for. We treat the homepage as a junction with clearly labeled routes rather than a single scrolling argument that tries to carry the science, the commercial pitch, and the proof all at once.

Which route takes visual priority is the decision that stakeholder alignment should already have settled. When the scientific audience ranks first, evidence leads and the commercial route sits confidently alongside it. When the commercial motion ranks first, capabilities lead and the science becomes the proof beneath them. The architecture expresses that ranking rather than hiding from it.

Model content as structured data, not pages

The sections that make a life sciences site distinctive are the ones that change. Pipeline programs advance. Publications accumulate. Data readouts update. Team members join and leave. When these live as hand-built pages, they fall out of date and the site loses credibility with the scientific reader who notices first.

We model them as structured content types instead. A publication is a record with authors, a journal, a date, and a link, not a paragraph someone pasted. A pipeline program is a record with a stage, an indication, and a status. Structured content can be filtered, sorted, and kept current without a redesign, and it is also what makes a thoughtful approach to presenting pipeline, publications, and data possible in the first place. This modeling decision shapes the platform you will eventually need, which is why it connects directly to choosing the right technology for the redesign.

Keep navigation flat and legible

Faceted, deeply nested navigation feels sophisticated and performs poorly. On a site where a scientist may arrive from a search result deep in the publication list and a buyer may arrive on the homepage, every page needs to tell the reader where they are and where they can go next. We favor a flat, legible structure over a clever one, because the reader who lands three levels deep from a search engine has no memory of a journey they never took.

Practically, that means a navigation that exposes the main routes without hiding them behind hover states, breadcrumbs that orient a deep-landing visitor, and section labels that say plainly what they contain. A buyer should never have to pass through the science to reach capabilities, and a scientist should never have to pass through the sales pitch to reach a method.

Write each section in the register its reader trusts

Structure is not only layout. It is also voice. The scientific sections should read with the precision a technical reader expects, and the commercial sections should read with the clarity a buyer expects, without the two colliding on a single page. A capabilities page that lapses into dense methodology loses the buyer, and a pipeline page that reaches for marketing language loses the scientist. The architecture should keep these registers in their own rooms even as the brand holds them together.

Validate the structure against real journeys

Before a structure is final, we walk it as each reader would. Can a principal investigator reach a relevant publication and the method behind it quickly. Can a procurement lead reach capabilities, compliance posture, and a contact route without detour. Where the two paths cross, the structure needs a deliberate handoff rather than an accident. This is the same lens the opening website audit applied to the old site, now turned toward the new one.

Our structural work for research-driven partners such as Taconic Biosciences and CLSI began from exactly this premise, that two audiences deserve two clean paths through one coherent site. If you want a broader view of how a specialist partner handles this, what to expect from a life science marketing agency sets the context.